Dehradun Police Seizes 68,000 Caps Of Controlled Drugs

DEHRADUN : Dehradun police recovered a drug haul comprising 68,000 Caps comprising a painkiller and an anti-anxiety prescription medicine which are reported to be worth Rs 50 lakh in the black market from two medical stores in the Premnagar area in the wee hours of Sunday.

It is the biggest recovery of such prescription drugs by Dehradun police, said the senior superintendent of police Daleep Singh Kunwar in a Press conference here on Sunday. He said that the police received a tip-off through an informer late on Saturday evening that the operators of Vansh Medical Store near Sudhowala Chowk have been selling controlled drugs without prescription.

A police team led by a circle officer of Premnagar conducted a raid on the medical store where medical store operator Krishna Kumar (42) along with his brother Vinay Kumar (40) was allegedly caught selling the drugs.

He said that the police team recovered a huge consignment of drugs from the medical store including 68,000 capsules of controlled drugs. “The accused stated in the preliminary inquiry that they sell prescription drugs to students and labourers under the pretext of selling medicines in their chemist shop.

They are allegedly been running that shop since 2013 and possess no valid license required to run a chemist shop. They sell controlled substances to students and labourers at higher prices to earn quick profits as these drugs cannot be acquired without a valid prescription from a doctor,” said Kunwar.

He said that both accused have allegedly confessed to buying the controlled drugs from a man named Indrajeet who resides in the Race Course area. The SSP said that the police are investigating the matter and will take action against all culprits involved in the case under the Gangster Act. Kunwar and the inspector general of the Garhwal range, Karan Singh Nagnyal have also announced a reward of Rs 20,000 and Rs 40,000 respectively to the police team.

  • Related Posts

    Andelyn Biosciences partners with Queen’s University to develop and manufacture gene therapy AAV9-GM2 to treat GM2 gangliosidoses

    Andelyn bio sciences Inc, a leading patient-focused cell and gene therapy Contract Development and Manufacturing Organization (CDMO), has partnered with Queen’s University to develop and manufacture AAV9-GM2, a gene therapy…

    Cellution Biologics completes acquisition of SimpliDerm business for US$ 8 million from Elutia

    Cellution Biologics Inc, a biologics company focused on developing, manufacturing and commercializing advanced human tissue-based products, announced the completion of its acquisition of the SimpliDerm hydrated human acellular dermal matrix…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Andelyn Biosciences partners with Queen’s University to develop and manufacture gene therapy AAV9-GM2 to treat GM2 gangliosidoses

    Andelyn Biosciences partners with Queen’s University to develop and manufacture gene therapy AAV9-GM2 to treat GM2 gangliosidoses

    Cellution Biologics completes acquisition of SimpliDerm business for US$ 8 million from Elutia

    Cellution Biologics completes acquisition of SimpliDerm business for US$ 8 million from Elutia

    ACB Gujarat arrested two FDA Officials red-handed in Bharuch accepting a bribe of ₹40,000

    ACB Gujarat arrested two FDA Officials red-handed in Bharuch accepting a bribe of ₹40,000

    US appeals court sides with Sun Pharma in Lipitor antitrust case

    US appeals court sides with Sun Pharma in Lipitor antitrust case

    Counterfeit Cosmetics Are No Longer a Fringe Problem: 4 in 10 Consumers Report Fake Products, Regulatory Silence Raises Serious Questions

    Counterfeit Cosmetics Are No Longer a Fringe Problem: 4 in 10 Consumers Report Fake Products, Regulatory Silence Raises Serious Questions

    Three arrested for illegal sale of mephentermine sulphate injections in Hyderabad

    Three arrested for illegal sale of mephentermine sulphate injections in Hyderabad